KathrynMcconnellGrevenMDFASTRO

Radiation Oncology • Winston Salem, NC

Gynecologic Cancer, Head & Neck

Professor of Radiation Oncology, Wake Forest University

Join to view full profile

Dr. Greven is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Greven's full profile

Already have an account?

Office
S Hawthorne Rd
Winston Salem, NC 27157
Phone+1 336-713-3600

Fax+1 336-713-6565

Education & Training

Wake Forest University Baptist Medical CenterResidency, Radiation Oncology, 1984 - 1987
Wake Forest University Baptist Medical CenterInternship, Transitional Year, 1983 - 1984
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1983

Certifications & Licensure

NC State Medical License 1985 - 2024
PA State Medical License 1987 - 1990
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Fellow American Society of Therapeutic Radiation and Oncology

Clinical Trials

Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer Start of enrollment: 2000 Aug 01
Completed
Phase 3
Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer Start of enrollment: 2000 Oct 01
Completed
Phase 3
PET Scans and CT Scans in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy Start of enrollment: 2006 Feb 01
Completed
L-Arginine Supplements in Treating Women Who Are Cancer Survivors Start of enrollment: 2007 May 01
Completed
Not Applicable
Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer Start of enrollment: 2008 Mar 01
Terminated
Phase 1, Phase 2
RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2010 Mar 31
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

8 citations
Comparing Outcomes for Patients with Human Papillomavirus (HPV) Type 16 versus Other High-Risk HPV Types in Oropharyngeal Squamous Cell Carcinoma
R.F. Shenker, Nelson H. May, Joshua D. Waltonen, Jae Paul Yang, Stacey S O'Neill
Head and Neck Pathology. 2021-02-22
463 citations
Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG).
Gordon J. S. Rustin, Ignace Vergote, Elizabeth Eisenhauer, Eric Pujade-Lauraine, Michael A. Quinn
International Journal of Gynecological Cancer. 2011-02-01
57 citations
Isolated vaginal recurrences of endometrial adenocarcinoma and their management.
Kathryn M. Greven, Warren W. Olds
Cancer. 1987-08-01